This targeted inhibition effectively impedes the cellular uptake and influx of extracellular Cys2, thereby indirectly suppressing GPX4 enzymatic activity and ultimately leading to the highly efficient induction of ferroptosis in tumor cells. Here, GPX4 is linked to neoplasm.